Clarithromycin Patent Expiration
Clarithromycin is Used for treating mild to moderate infections caused by susceptible strains. It was first introduced by Abbvie Inc
Clarithromycin Patents
Given below is the list of patents protecting Clarithromycin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Biaxin Xl | US6551616 | Extended release formulations of erythromycin derivatives |
Jul 15, 2017
(Expired) | Abbvie |
| Biaxin Xl | US6010718 | Extended release formulations of erythromycin derivatives |
Apr 11, 2017
(Expired) | Abbvie |
Clarithromycin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List